Overview

An Ascending Dose, Single/Multiple Dosing, Food Effect Clinical Trial to Evaluate Pharmacokinetics, Safety and Tolerability in Healthy Subjects After Oral Administration of Gemigliptin (Phase I)

Status:
Completed
Trial end date:
2020-02-28
Target enrollment:
Participant gender:
Summary
To determine the pharmacokinetic properties, safety and tolerability of single/multiple oral administration of Gemigliptin and Food effect in healthy Chinese subjects.
Phase:
Phase 1
Details
Lead Sponsor:
LG Chem